Compass Pathways Plc (CMPS)
7.13
+0.13
(+1.86%)
USD |
NASDAQ |
Jan 22, 16:00
7.21
+0.08
(+1.12%)
After-Hours: 16:35
Compass Pathways EPS Diluted (Quarterly): -1.436 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Biodexa Pharmaceuticals Plc | -- |
| NuCana Plc | -0.1348 |
| Autolus Therapeutics Plc | -0.2955 |
| Tiziana Life Sciences Ltd. | -- |
| Aptorum Group Ltd. | -- |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -136.89M |
| Total Expenses (Quarterly) | 136.89M |
| Enterprise Value | 520.99M |
| Earnings Yield | -37.59% |
| Normalized Earnings Yield | -29.10 |